Alexion Pharmaceuticals updated its FY18 earnings guidance on Thursday. The company provided earnings per share guidance of $6.60-6.80 for the...
Read moreThe deal comes after Ablynx rejected the second acquisition proposal made by Denmark’s Novo Nordisk earlier this month for €2.5bn,...
Read moreSanofi announced that on February 7, 2018 it commenced a tender offer (the “Offer”) to acquire all of the outstanding...
Read moreRoche and Ignyta, Inc. today announced that Roche’s wholly owned subsidiary Abingdon Acquisition Corp., has accepted for payment all shares...
Read moreOrganovo Holdings, Inc. will host a conference call on Thursday, February 8, 2018 at 5:00 p.m. Eastern Time (ET) to...
Read moreStrongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases...
Read moreAgilent Technologies Inc. announced it has acquired Cork, Ireland-based Luxcel Biosciences ("Luxcel"), a developer of real-time fluorescence plate-reader based in...
Read moreThermo Fisher Scientific and Illumina, Inc. announced they have signed a commercial agreement that enables Illumina to sell Ion AmpliSeq...
Read moreLivaNova PLC, a market-leading medical technology company, announced it has entered into an agreement to acquire the remaining outstanding interests...
Read morePMC Group France, a wholly owned subsidiary of PMC Group International Inc., which is an independent arm of PMC Group...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.